These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39015682)
1. Prolonged Impella 5.0/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center. Pieri M; Ortalda A; Altizio S; Bertoglio L; Nardelli P; Fominskiy E; Lapenna E; Ajello S; Scandroglio AM Front Cardiovasc Med; 2024; 11():1379199. PubMed ID: 39015682 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group. Fried J; Farr M; Kanwar M; Uriel N; Hernandez-Montfort J; Blumer V; Li S; Sinha SS; Garan AR; Li B; Hall S; Hickey GW; Mahr C; Nathan S; Schwartzman A; Kim J; Ton VK; Vishnevsky OA; Vorovich E; Abraham J; Zweck E; Guglin M; Vallabhajosyula S; Kataria R; Walec KD; Zazzali P; Kong Q; Sangal P; Burkhoff D; Kapur NK J Heart Lung Transplant; 2024 Sep; 43(9):1478-1488. PubMed ID: 38834162 [TBL] [Abstract][Full Text] [Related]
3. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach. Tschöpe C; Spillmann F; Potapov E; Faragli A; Rapis K; Nelki V; Post H; Schmidt G; Alogna A Front Cardiovasc Med; 2021; 8():563484. PubMed ID: 33681302 [No Abstract] [Full Text] [Related]
4. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access. Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682 [TBL] [Abstract][Full Text] [Related]
5. Impella as Bridge to Durable Left Ventricular Assist Device in Acute Myocardial Infarction Cardiogenic Shock Patients. Ajello S; Pieri M; Dormio S; Baldetti L; Altizio S; Consolo F; Nardelli P; Ortalda A; Scandroglio AM ASAIO J; 2024 Nov; 70(11):e150-e152. PubMed ID: 38537063 [TBL] [Abstract][Full Text] [Related]
6. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock. Haertel F; Lenk K; Fritzenwanger M; Pfeifer R; Franz M; Memisevic N; Otto S; Lauer B; Weingärtner O; Kretzschmar D; Dannberg G; Westphal J; Baez L; Bogoviku J; Schulze PC; Moebius-Winkler S J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956238 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device. Radakovic D; Zittermann A; Knezevic A; Razumov A; Opacic D; Wienrautner N; Flottmann C; Rojas SV; Fox H; Schramm R; Morshuis M; Rudolph V; Gummert J; Deutsch MA Interact Cardiovasc Thorac Surg; 2022 Jan; 34(1):137-144. PubMed ID: 34999807 [TBL] [Abstract][Full Text] [Related]
8. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival. Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726 [TBL] [Abstract][Full Text] [Related]
9. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047 [TBL] [Abstract][Full Text] [Related]
10. Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry. Iannaccone M; Franchin L; Burzotta F; Botti G; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Masiero G; Di Biasi M; Pagnotta P; Casu G; Scandroglio AM; Tarantini G; Chieffo A J Pers Med; 2023 May; 13(5):. PubMed ID: 37240996 [TBL] [Abstract][Full Text] [Related]
11. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience. Matassini MV; Marini M; Angelozzi A; Angelini L; Shkoza M; Compagnucci P; Falanga U; Battistoni I; Pongetti G; Francioni M; Piva T; Mucaj A; Nicolini E; Maolo A; Di Eusanio M; Munch C; Dello Russo A; Perna G Front Cardiovasc Med; 2023; 10():1171956. PubMed ID: 37416919 [TBL] [Abstract][Full Text] [Related]
13. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre. Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259 [TBL] [Abstract][Full Text] [Related]
14. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière. Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912 [TBL] [Abstract][Full Text] [Related]
15. Outcome of the impella device for acute mechanical circulatory support. Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788 [TBL] [Abstract][Full Text] [Related]
16. Temporary Mechanical Circulatory Support in Patients with Cardiogenic Shock: Clinical Characteristics and Outcomes. Abiragi M; Singer-Englar T; Cole RM; Emerson D; Esmailian F; Megna D; Moriguchi J; Kobashigawa JA; Kittleson MM J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836157 [TBL] [Abstract][Full Text] [Related]
17. Early experience with the Impella pump: Single-center registry. Zubarevich A; Arjomandi Rad A; Szczechowicz M; Luedike P; Koch A; Pizanis N; Kamler M; Ruhparwar A; Weymann A; Schmack B Artif Organs; 2022 Aug; 46(8):1689-1694. PubMed ID: 35377470 [TBL] [Abstract][Full Text] [Related]
18. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy. Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975 [TBL] [Abstract][Full Text] [Related]
19. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719 [TBL] [Abstract][Full Text] [Related]
20. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre. Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]